A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants
Clinical trial NCT06612970 · RECRUITING
Trial details
- NCT number
- NCT06612970
- Sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-18
- Primary completion
- 2025-06-13
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.